AMECATH CVC AND AMECATH PRESSURE CVC SHORT TERM SINGLE AND MULTI-LUMEN CATHERIZATION KITS

K110794 · Ameco Medical Industries · FOZ · Dec 21, 2011 · General Hospital

Device Facts

Record IDK110794
Device NameAMECATH CVC AND AMECATH PRESSURE CVC SHORT TERM SINGLE AND MULTI-LUMEN CATHERIZATION KITS
ApplicantAmeco Medical Industries
Product CodeFOZ · General Hospital
Decision DateDec 21, 2011
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 880.5200
Device ClassClass 2
AttributesTherapeutic

Intended Use

Indicated to permit short-term (<30 day) central venous access for the treatment of diseases or conditions requiring central venous access, including, but not limited to the following: - Lack of usable peripheral IV sites . - Central venous pressure monitoring . - Total parenteral nutrition (TPN) . - . Multiple infusions of fluids, medications, or chemotherapy - Frequent blood sampling or receiving blood transfusions/blood products . - . Infusions that are hypertonic, hyperosmolar, or infusions that have divergent pH values - Injection of contrast media in pressure CVC only . When used for pressure injection of contrast media, do not exceed the maximum indicated flow rate for each catheter lumen. The maximum pressure of power injector equipment used with the pressure injectable CVC may not exceed 300psi.

Device Story

Amecath CVC and Amecath Pressure CVC are short-term, single and multi-lumen catheterization kits designed for central venous access. Devices provide a conduit for fluid administration, medication delivery, chemotherapy, TPN, blood sampling, and CVP monitoring. Pressure CVC variants allow for power injection of contrast media. Used in clinical settings by healthcare professionals. Catheters are inserted into the central venous system to facilitate therapy when peripheral IV access is insufficient. Benefits include reliable venous access for complex treatments and diagnostic imaging. Operation involves standard catheterization techniques; pressure injection requires adherence to flow rate limits and a maximum pressure of 300 psi for power injectors.

Clinical Evidence

No clinical data provided; substantial equivalence is based on bench testing and technological comparison.

Technological Characteristics

Short-term (<30 day) intravascular catheter kits; single and multi-lumen configurations; pressure-injectable variants; materials compliant with biocompatibility standards for intravascular use; non-implantable; manual insertion technique.

Indications for Use

Indicated for patients requiring short-term (<30 days) central venous access for fluid/medication infusion, TPN, blood sampling/transfusion, CVP monitoring, or contrast media injection (pressure CVC only).

Regulatory Classification

Identification

An intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings and that is inserted into the patient's vascular system for short term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravenously. The device may be constructed of metal, rubber, plastic, or a combination of these materials.

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes extending from its head, representing health, human services, and well-being. The eagle is positioned to the right of the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA", which is arranged in a circular fashion around the left side of the eagle. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 DEC 2 1 2011 Ameco Medical Industries C/O Mr. Ray Kelly RA/QA Specialist Rav Kelly 79 Brookline Road Mason, New Hampshire 03048 Re: K110794 Trade/Device Name: Amecath CVC and Amecath Pressure CVC short term single and multi-lumen catheterization kits Regulation Number: 21 CFR 880.5200 Regulation Name: Intravascular Catheter Regulatory Class: Class II Product Code: FOZ Dated: December 15, 2011 Received: December 19, 2011 Dear Mr. Kelly: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ ## Page 2 - Mr. Kelly Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices /ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, Nh for Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows a black-and-white drawing of a building. The building has a symmetrical design with a central entrance and two wings on either side. The wings have a grid-like pattern, possibly representing windows. The building is topped with a decorative roof structure. Ameco Medical Industries Industrial area B4 # 119 east, 10th of Ramadan city -Egypt Phone +20.15.383.066/7 | Fax +20.15.383.068 | www.amecath.com ## Section 3 ## INDICATIONS FOR USE 510(k) Number (if known): Device Name: "Amecath CVC" and "Amecath Pressure CVC" short term single and multi-lumen catheterization kits Indications For Use: Indicated to permit short-term (<30 day) central venous access for the treatment of diseases or conditions requiring central venous access, including, but not limited to the following: - Lack of usable peripheral IV sites . - Central venous pressure monitoring . - Total parenteral nutrition (TPN) . - . Multiple infusions of fluids, medications, or chemotherapy - Frequent blood sampling or receiving blood transfusions/blood products . - . Infusions that are hypertonic, hyperosmolar, or infusions that have divergent pH values - Injection of contrast media in pressure CVC only . When used for pressure injection of contrast media, do not exceed the maximum indicated flow rate for each catheter lumen. The maximum pressure of power injector equipment used with the pressure injectable CVC may not exceed 300psi. Prescription Use V (Part 21 CFR. 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR. 801 Subpart C) 5 (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) --- (Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices 510(k) Number: k110794
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%